|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: OFFICEMAX INC /OH/, 10-Q, 2000-05-31 |
Next: INKINE PHARMACEUTICAL CO INC, S-3/A, 2000-05-31 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from consolidated
balance sheets and consolidated statements of operations and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JAN-27-2000
<PERIOD-START> JAN-22-2000
<PERIOD-END> APR-22-2000
<CASH> 72,232
<SECURITIES> 0
<RECEIVABLES> 87,972
<ALLOWANCES> 485
<INVENTORY> 1,255,332
<CURRENT-ASSETS> 1,473,963
<PP&E> 720,592
<DEPRECIATION> 331,326
<TOTAL-ASSETS> 2,204,892
<CURRENT-LIABILITIES> 988,052
<BONDS> 0
0
0
<COMMON> 867,539
<OTHER-SE> 246,424
<TOTAL-LIABILITY-AND-EQUITY> 2,204,892
<SALES> 1,344,188
<TOTAL-REVENUES> 1,344,188
<CGS> 1,016,696
<TOTAL-COSTS> 1,016,696
<OTHER-EXPENSES> 318
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (1,531)
<INCOME-PRETAX> (1,141)
<INCOME-TAX> 253
<INCOME-CONTINUING> (2,083)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,083)
<EPS-BASIC> (.02)
<EPS-DILUTED> (.02)
</TABLE>
|
|